AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studyNot reportedTrial registry
Human Study on Serum Cytokine TWEAK in Multiple Sclerosis
A study involving 50 human subjects investigated the serum concentration of the cytokine TWEAK over a year. It was observed that variations in TWEAK levels correlate with inflammatory disease outbreaks in Multiple Sclerosis (MS).
- Tags
- #Biomarkers
- Most relevant to
- —
- Source
- Read original source
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Why it matters
Understanding the role of TWEAK in MS may provide insights into inflammatory processes and indicate potential biomarkers for monitoring disease activity.
What this does not prove
As results are not posted, the findings are preliminary and do not confirm causation or effective treatment effects. Planned enrollment and endpoints do not constitute findings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- 50 · basis not reported
- Randomised
- No
- Controlled
- Not applicable
- Primary endpoint met
- Not reported
- Relevant MS type
- All
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- No
- Research areas
- Biomarkers
Original sources
Supporting passages (12)
randomized"allocation": "NA"
controlled"allocation": "NA"
regulatory approval"isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false
research categoriesTWEAK (TNF-related weak inducer of apoptosis or TNFSF12) is a pro-inflammatory cytokine member of the TNF family.
relevant ms typesconditions": [ "Multiple Sclerosis" ]
interventionDiagnostic Test: Determination of the circulating serum concentration of cytoquine TWEAK
primary endpoint"measure": "The serum concentration of soluble TWEAK"
subjectsA significant variation in the serum concentration of the circulating cytokine TWEAK is associated with the onset of an inflammatory attack of MS.
sample sizecount": 50, "type": "ESTIMATED"
follow up"timeFrame": "1 year"
findingsA significant variation in the serum concentration of the circulating cytokine TWEAK is associated with the onset of an inflammatory attack of MS.
limitationsNo results are posted. Planned enrolment and endpoints are not findings.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.